 您的位置：对照品 > 标准物质 > 环保部标准物质 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：C596485 |
| 产品名称：(2S)-2-(2-Chlorophenyl)-2-(1-methoxy-1-methylethoxy)Ethyl Ester 1H-Imidazole-1-carboxylic |
| 产品CAS：1146981-97-6 |
| 规格含量：25mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
C596485 |
| 名称: |
(2S)-2-(2-Chlorophenyl)-2-(1-methoxy-1-methylethoxy)Ethyl Ester 1H-Imidazole-1-carboxylic Acid |
| 别名: |
(S)-2-(2-Chlorophenyl)-2-((2-methoxypropan-2-yl)oxy)ethyl 1H-Imidazole-1-carboxylate |
| CAS号: |
1146981-97-6 |
| 分子式: |
C₁₆H₁₉ClN₂O₄ |
| 分子量: |
338.79 |
| 类别: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
(2S)-2-(2-Chlorophenyl)-2-(1-methoxy-1-methylethoxy)Ethyl Ester 1H-Imidazole-1-carboxylic Acid is an intermediate in the synthesis of (S)-Carisbamate (C183510). Carisbamate is being developed for adjuvant treatment of partial onset epilepsy. Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models. |
| 参考文献 |
|
|
|
|
|
|
